National Association of Testing Authorities, Australia
Scope of Accreditation
Royal Perth Hospital - Cell and Tissue Therapies WA (CTTWA)
Site
Cell & Tissue Therapies WA (CTTWA)
Accreditation No.
19786
Site No.
23076
Date of Accreditation
22 Oct 2015
Contact
Dr Zlatibor Velickovic P: +61 (08) 92241987
Availability
Services not available to external clients
Supervision
HPS (Haemopoietic processing, storage)
Scope of Accreditation
Cell & Tissue Therapies WA (CTTWA)
ISO 15189 (2012)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Service | Product | Determinant |
---|---|---|
Haematology - Full blood examination | Blood | Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Mean corpuscular haemoglobin (MCH); Mean corpuscular haemoglobin concentration (MCHC); Mean platelet volume (MPV); Platelet count; Red blood cell distribution width (RDW) |
Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood; Bone marrow | CD16; CD19; CD3; CD34; CD4; CD45; CD56; CD8; Total leucocyte number; Total lymphocyte number; Viable cell count |
Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cellsProducts received from AN 19801 SN 23095 and AN 19786 SN 23076 | Bone marrow; Cord blood; Haemopoietic progenitor cells | Processing; Storage (includes freezing/thawing) |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
19786
Site No.
23076
Print date
08 Oct 2024
END OF SCOPE